SCHEMBL4600987

SCHEMBL4600987

O=CCCc1ccc(Oc2ccccc2)nn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCAT2 O15382 1/20 0.47
MCHR1 Q99705 5/20 0.40
CHRM1 P11229 1/20 0.40
HTR2A P28223 1/20 0.39
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 2/20 0.34
GAA P10253 2/20 0.34
LTA4H P09960 2/20 0.33
TSHR P16473 1/20 0.33
HAO1 Q9UJM8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4591085 0.76 BCAT2 (0.53) BCAT2MCHR1CHRM1HTR2AKMT2A
SCHEMBL4592135 0.76 MCHR1 (0.53) BCAT2MCHR1CHRM1HTR2ASMN1; SMN2
SCHEMBL4276104 0.75 BCAT2 (0.75) BCAT2KMT2AMEN1SMN1; SMN2L3MBTL1
SCHEMBL28022446 0.74 OPRM1 (0.47) L3MBTL1LTA4HACACBALDH1A1ACACA
Diphenylether SCHEMBL5161616 0.71 LTA4H (0.60) KMT2ALMNAGAALTA4HTSHR
SCHEMBL7185148 0.69 FFAR1 (0.58) LTA4HTSHR
SCHEMBL4591505 0.69 MCHR1 (0.67) BCAT2MCHR1CHRM1HTR2ALTA4H
SCHEMBL2993288 0.68 MCHR1 (0.57) BCAT2MCHR1CHRM1HTR2ALMNA
SCHEMBL2561043 0.67 ALDH1A1 (0.44) GAAALDH1A1
SCHEMBL8495830 0.67 HRH1 (0.61) HTR2AKMT2AL3MBTL1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943231-A1 (HETERO)ARYL COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-07-16 EP disclosed
US-20070111981-A1 New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds ROTH GERALD J 2007-05-17 US disclosed
WO-2007048802-A1 (HETERO)ARYL COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070111981-A1 New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds MCHR1, GPR119, MCHR2 BCAT2 353/4885MCHR1 1/4885CHRM1 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.